Showing posts with label Jan Aushadhi scheme. Show all posts
Showing posts with label Jan Aushadhi scheme. Show all posts

Monday, April 1, 2019

Govt plans to specify a unique colour code for generic medicines

479245748

Company News

The central government is favourably considering an amendment to the decades-old Drugs and Cosmetics Rules, to specify a separate colour code for generic medicines, from branded medicines.
A generic is a copy of a formerly patented drug. Of two types, branded and unbranded. Generic medicines might or might not have a trade name, as opposed to branded generics. They are made by small and large companies alike but not marketed through the doctor-channel; instead, these are pushed directly into the trade.

A senior government official said they were actively considering a proposal to introduce colour codes on the lines of the red and green dots to differentiate between vegetarian and non-vegetarian food products.

“Generic medicines are gaining popularity and available more easily in the mainstream channel. There is a need to differentiate these from branded generics. At times generic medicines, too, have a trade name and this leads to confusion. To address the issue, the government is considering colour codes and symbols on medicine packs,” he said.

Generic medicines are made by both state-owned and private entities, whether big, medium-sized or small. For big pharmaceutical firms, it is a volume game. They sell these directly to the trade after adding a margin. From the first point of sale (distributor or stockist) to the consumer, the margin in this segment varies from 20 per cent to 90 per cent, says the industry.


 The Pradhan Mantri Jan-Aushadhi scheme aims to provide quality drugs at a 50-90 per cent discount on their branded counterparts. It is because of this price differential between generic and branded medicines that the government also thinks it is important to have a separate colour code.

Friday, March 22, 2019

Charticle: How Jan Aushadhi stores are disrupting the Indian pharma market

Companies News

* The growth of the Indian Pharma market has come down from 13.5 per cent in FY15 to 10 per cent YoY in FY18

* Analysts point out that growth from product introductions has nearly halved over the last two years as the drug regulator has been more stringent about new combination drugs

* Growing awareness about cheaper alternatives to branded generics and more channels providing access to them has started to impact volume growth for branded generics

* The Government's push towards Jan Aushadhi stores has started to impact volumes of branded generics

* The Pradhan Mantri Jan Aushadhi scheme aims to provide quality drugs at almost 50-90% discount to their branded counterparts

* Jan Aushadhi stores cover a list of 800 plus drugs, both chronic and acute, across therapies like anti-cancer, anti-infective, reproductive and gastro intestinal medicines

* There are 5000+ Jan Aushadhi stores now and another 2500 to be opened by 2020

* Edelweiss noted revenue of the Jan Aushadhi scheme is expected to double YoY in FY19. Revenue of Rs 300 crore expected in FY19

* Can potentially disrupt 1% of IPM


 * Edelweiss noted that the Rs 120 crore sales of BPPI in FY18 corresponds to Rs 600 crore of branded products.